Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES | 10 | - | -1,10 % | ||
| MODERNA | 9 | 16 | +1,97 % | ||
| INSMED | 6 | 7 | +5,43 % | ||
| MADRIGAL PHARMACEUTICALS | 6 | 7 | -7,82 % | ||
| NEWAMSTERDAM PHARMA | 6 | - | -3,29 % | ||
| AMGEN | 4 | 27 | -0,20 % | ||
| REGENERON PHARMACEUTICALS | 4 | 22 | -1,13 % | ||
| ATAIBECKLEY | 4 | - | -4,44 % | ||
| COMPASS PATHWAYS | 3 | 11 | 0,00 % | ||
| HALOZYME THERAPEUTICS | 3 | 6 | -1,77 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18:45 | CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows | 1 | MarketBeat | ||
| 18:27 | White House frustration may have fueled FDA's Moderna walkback: Politico | 3 | FierceBiotech | ||
| 18:10 | Insmed CEO explains 'audacious' $1B projection for 2026 sales of Brinsupri | 3 | FiercePharma | ||
| 18:06 | Tempus AI Stock Jumps As Mizuho Starts Coverage, Earnings Scheduled For Next Week | 1 | Benzinga.com | ||
| 17:54 | Madrigal outlines robust 2026 net sales growth and expanding pipeline amid 50% MASH market surge | 3 | Seeking Alpha | ||
| 17:30 | Benchmark raises Halozyme stock price target to $90 on strong results | 1 | Investing.com | ||
| 17:10 | Merck to seek 2nd-season RSV nod for Enflonsia in hot pursuit of Sanofi, AstraZeneca's Beyfortus | 3 | FiercePharma | ||
| 16:54 | Cantor Fitzgerald reiterates NewAmsterdam Pharma stock rating at Overweight | 1 | Investing.com | ||
| 16:50 | Johnson Fistel, PLLP: Ocular Therapeutix Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses | 201 | Newsfile | San Diego, California--(Newsfile Corp. - February 19, 2026) - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Ocular Therapeutix, Inc. (NASDAQ: OCUL). The investigation... ► Artikel lesen | |
| 16:50 | Johnson Fistel, PLLP: Zevra Therapeutics Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses | 170 | Newsfile | San Diego, California--(Newsfile Corp. - February 19, 2026) - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Zevra Therapeutics, Inc. (NASDAQ: ZVRA). The investigation... ► Artikel lesen | |
| 16:26 | J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy | 3 | FierceBiotech | ||
| 16:06 | P/E Ratio Insights for Amgen | 3 | Benzinga.com | ||
| 15:58 | TD Cowen bestätigt Kaufempfehlung für Amgen wegen Pipeline-Potenzial | 10 | Investing.com Deutsch | ||
| 15:58 | Madrigal: Starker Rezdiffra-Umsatz kann deutliche Gewinnverfehlung nicht ausgleichen | 3 | Investing.com Deutsch | ||
| 15:54 | TD Cowen reiterates Buy on Amgen stock citing pipeline potential | 5 | Investing.com | ||
| 15:54 | Kehrtwende bei der FDA: Behörde prüft Modernas Grippeimpfstoff doch | 9 | Pharmazeutische Zeitung | ||
| 15:46 | Earnings call transcript: Praxis Precision verfehlt EPS-Prognose für Q4 2025 | 9 | Investing.com Deutsch | ||
| 15:42 | ImmunityBio forms Irish unit, distribution deal to improve Anktiva access in Europe | 9 | Seeking Alpha | ||
| 15:42 | Truist reiterates Praxis Precision Medicines stock rating on pricing potential | 3 | Investing.com | ||
| 15:29 | AtaiBeckley Appoints Michael Faerm As New CFO | 5 | RTTNews |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.